Watch ISD Videos Now Listen to ISD Radio Now

Covaxin trials showing good results but why is the left liberal media not interested in talking about it?

The 1st phase of Covaxin human trials has been completed successfully. And now, the trials for the 2nd phase are going on throughout the country. Covaxin is India’s very own indigenous COVID 19 vaccine and if all goes well, the vaccine would be out in the public domain very soon this year.

The baffling thing though is that the country’s media, especially the left liberal media, that caters to a large section of elite English speaking crowd, doesn’t seem to be too enthusiastic about India’s 1st ever indigenous  COVID 19 vaccine.

While the left liberal media is waxing eloquently on every small development regarding the progress made by COVID 19 Oxford vaccine, singing paeans of praise for the promises it holds for the world at large, it is giving a rather lopsided, cold coverage to Covaxin, that is being produced by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR).

It’s clearly a case of dancing to the tunes of global pharmaceutical lobby, paying homage to the global hegemony. And in this global hegemony, the Oxford vaccine is technically speaking, a very major player. In the production of this vaccine, alongwith the Serum Institute of India, AstraZeneca is involved which is a British-Swedish multinational pharmaceutical and biopharmaceutical company. The vaccine is being primarily produced by Oxford University. The Serum Institute of India is a small player in this vaccine and its main role lies in making arrangements for human trials in India and producing the vaccine in mass quantities for the Indian market. The vaccine is ostensibly being manufactured for India and middle and low income countries across the world.

So despite the sugar coated terminology and the Indian partnership notwithstanding, this vaccine is essentially an imported vaccine for which the Indian government would be spending the taxpayers’ hard earned money, should it choose to import this vaccine. And the fact that the vaccine is being manufactured for people of middle and low income countries like India itself puts the credibility of the vaccine to question mark. One is forced to thing do the vaccine manufacturers want to use people from developing and underdeveloped countries as guinea pigs before deciding to administer the vaccine to their developed counterparts?

On the contrary, Covaxin is an indigenous vaccine being developed by Bharat Biotech, a company which has a proven track record in making affordable vaccines for Indians. Bharat Biotech made the world’s most affordable vaccine for Hepatitis. It is the same company that produced the world’s first ever Zika virus vaccine.

So once this vaccine is out in the public domain, in all probability, it would be way cheaper than the Oxford vaccine. So in a country where people still can’t even afford to pay for basic healthcare services, many struggle to get two square meals a day, why is the media over promoting a super expensive vaccine being produced by a developed country? On the other hand, there is an indigenous vaccine being developed by a local company, a company the founder of which is a farmer’s son, he started the company from a scratch and had difficulty getting funds in the initial stages. So the priorities of the Indian left liberal media seem to be clear here. They are playing the role maintaining the global hegemony of the big pharma and indirectly discouraging small scale players in the field.

Join our Telegram Community to ask questions and get latest news updates
आदरणीय पाठकगण,

ज्ञान अनमोल हैं, परंतु उसे आप तक पहुंचाने में लगने वाले समय, शोध, संसाधन और श्रम (S4) का मू्ल्य है। आप मात्र 100₹/माह Subscription Fee देकर इस ज्ञान-यज्ञ में भागीदार बन सकते हैं! धन्यवाद!  

Select Subscription Plan

OR

Make One-time Subscription Payment

Select Subscription Plan

OR

Make One-time Subscription Payment

Other Amount: USD



Bank Details:
KAPOT MEDIA NETWORK LLP
HDFC Current A/C- 07082000002469 & IFSC: HDFC0000708  
Branch: GR.FL, DCM Building 16, Barakhamba Road, New Delhi- 110001
SWIFT CODE (BIC) : HDFCINBB
Paytm/UPI/Google Pay/ पे / Pay Zap/AmazonPay के लिए - 9312665127
WhatsApp के लिए मोबाइल नं- 9540911078

Rati Agnihotri

Rati Agnihotri

रति अंग्रेज़ी और हिंदी दोनों में कवितायें लिखती हैं. इनका अंग्रेज़ी का पहला कविता संग्रह ‘ द सनसेट सोनाटा’साहित्य अकादमी से प्रकाशित हुआ है. रति की हिंदी कवितायें पाखी, संवदिया, परिकथा, रेतपथ, युद्धरत आम आदमी, हमारा भारत आदि साहित्यिक पत्रिकाओं में प्रकाशित हो चुकी हैं. रति दिल्ली में ‘ मूनवीवर्स – चांद के जुलाहे’ के नाम से एक पोएट्री ग्रुप चलाती हैं जहां कविता को संगीत, चित्रकला आदि विभिन्न विधाओं से जोड़ा जाता है और कविता से जुड़े विभिन्न पहलुओं पर विचार भी होता है. रति चीन के शिनुआ न्यूज़ एजेंसी के नई दिल्ली ब्यूरो में बतौर टी वी न्यूज़ रिपोर्टर कार्य कर चुकी हैं. रति आजकल स्वतंत्र पत्रकार के रूप में कार्यरत हैं. रति ने दिल्ली विश्वविद्यालय के मिरांडा हाउस कांलेज से अंग्रेज़ी विशेष में बी ए आनर्स किया है और इंग्लैंड के लीड्स विश्वविद्यालय से अंतराष्ट्रीय पत्रकारिता में एम ए किया है.

You may also like...

Write a Comment

ताजा खबर
हमारे लेखक